Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Shares Issued (2018 - 2021)

Historic Shares Issued for Iterum Therapeutics (ITRM) over the last 4 years, with Q3 2021 value amounting to -$5000.0.

  • Iterum Therapeutics' Shares Issued fell 10011.81% to -$5000.0 in Q3 2021 from the same period last year, while for Dec 2021 it was $89.6 million, marking a year-over-year increase of 2412.32%. This contributed to the annual value of $26.7 million for FY2024, which is 248133.46% up from last year.
  • Iterum Therapeutics' Shares Issued amounted to -$5000.0 in Q3 2021, which was down 10011.81% from $1.0 million recorded in Q2 2021.
  • Iterum Therapeutics' 5-year Shares Issued high stood at $88.6 million for Q1 2021, and its period low was -$72.8 million during Q4 2018.
  • In the last 4 years, Iterum Therapeutics' Shares Issued had a median value of $3.0 million in 2019 and averaged $8.4 million.
  • As far as peak fluctuations go, Iterum Therapeutics' Shares Issued surged by 9668163.27% in 2020, and later plummeted by 10011.81% in 2021.
  • Over the past 4 years, Iterum Therapeutics' Shares Issued (Quarter) stood at -$72.8 million in 2018, then soared by 104.09% to $3.0 million in 2019, then skyrocketed by 449.56% to $16.4 million in 2020, then tumbled by 100.03% to -$5000.0 in 2021.
  • Its last three reported values are -$5000.0 in Q3 2021, $1.0 million for Q2 2021, and $88.6 million during Q1 2021.